nigericin has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X; Liu, Y; Lv, R; Wang, Y; Wen, Q; Wu, P; Wu, X; Zhou, G | 1 |
| Gao, G; Han, Y; Kuang, Y; Liu, F; Wan, D; Wang, Q; Xu, Z; Zhi, Q | 1 |
| Alsaadi, M; Arkhipova, SS; Garanina, EE; Gilazieva, ZE; Hamza, S; Khaiboullina, SF; Markelova, MI; Martinova, EV; McIntyre, A; Rizvanov, AA; Tezcan, G | 1 |
1 review(s) available for nigericin and Neoplasms
| Article | Year |
|---|---|
Evidence of nigericin as a potential therapeutic candidate for cancers: A review.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Humans; Hydrogen-Ion Concentration; Ionophores; Neoplasms; Neoplastic Stem Cells; Nigericin; Photochemotherapy; Signal Transduction | 2021 |
2 other study(ies) available for nigericin and Neoplasms
| Article | Year |
|---|---|
P2X7 Receptor-Induced Bone Cancer Pain by Regulating Microglial Activity via NLRP3/IL-1beta Signaling.
Topics: Animals; Cancer Pain; Female; Inflammasomes; Interleukin-1beta; Lipopolysaccharides; Microglia; Neoplasms; NF-kappa B; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Receptors, Purinergic P2X7; RNA, Small Interfering; Signal Transduction | 2022 |
Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer.
Topics: A549 Cells; Antineoplastic Agents; Cell Proliferation; Cell Survival; Cytokines; Dipeptides; Humans; Inflammasomes; Inflammation Mediators; MCF-7 Cells; Mitochondria; Molecular Targeted Therapy; Neoplasms; Neovascularization, Pathologic; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; para-Aminobenzoates; PC-3 Cells; Signal Transduction | 2020 |